The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hurchla, M. A.
Right arrow Articles by Murphy, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hurchla, M. A.
Right arrow Articles by Murphy, K. M.
The Journal of Immunology, 2005, 174: 3377-3385.
Copyright © 2005 by The American Association of Immunologists

B and T Lymphocyte Attenuator Exhibits Structural and Expression Polymorphisms and Is Highly Induced in Anergic CD4+ T Cells 1

Michelle A. Hurchla*, John R. Sedy*, Maya Gavrielli*, Charles G. Drake{ddagger}, Theresa L. Murphy* and Kenneth M. Murphy2,*,{dagger}

* Department of Pathology and Center for Immunology, Washington University School of Medicine, {dagger} Howard Hughes Medical Institute, St. Louis, MO 63110; and {ddagger} Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD 21231

B and T lymphocyte attenuator (BTLA) was initially identified as expressed on Th1 cells and B cells, but recently reported to be expressed by macrophages, dendritic cells, and NK cells as well. To address this discrepancy we generated a panel of BTLA-specific mAbs and characterized BTLA expression under various activation conditions. We report the existence of three distinct BTLA alleles among 23 murine strains, differing both in Ig domain structure and cellular distribution of expression on lymphoid subsets. The BALB/c and MRL/lpr alleles differ at one amino acid residue, but C57BL/6 has nine additional differences and alters the predicted cysteine bonding pattern. The BALB/c BTLA allele is also expressed by B cells, T cells, and dendritic cells, but not macrophages or NK cells. However, C57BL/6 BTLA is expressed on CD11b+ macrophages and NK cells. Finally, in CD4+ T cells, BTLA is expressed most highly following Ag-specific induction of anergy in vivo, and unlike programmed death-1 and CTLA-4, not expressed by CD25+ regulatory T cells. These results clarify discrepancies regarding BTLA expression, suggest that structural and expression polymorphisms be considered when analyzing BTLA in various murine backgrounds, and indicate a possible role in anergic CD4+ T cells.




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
M. L. del Rio, C. L. Lucas, L. Buhler, G. Rayat, and J. I. Rodriguez-Barbosa
HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation
J. Leukoc. Biol., February 1, 2010; 87(2): 223 - 235.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Iwata, N. Watanabe, Y. Oya, T. Owada, K. Ikeda, A. Suto, S.-i. Kagami, K. Hirose, H. Kanari, S. Kawashima, et al.
Protective Roles of B and T Lymphocyte Attenuator in NKT Cell-Mediated Experimental Hepatitis
J. Immunol., January 1, 2010; 184(1): 127 - 133.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Sun, N. K. Brown, M. J. Ruddy, M. L. Miller, Y. Lee, Y. Wang, K. M. Murphy, K. Pfeffer, L. Chen, J. Kaye, et al.
B and T Lymphocyte Attenuator Tempers Early Infection Immunity
J. Immunol., August 1, 2009; 183(3): 1946 - 1951.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. Crawford and E. J. Wherry
Editorial: Therapeutic potential of targeting BTLA
J. Leukoc. Biol., July 1, 2009; 86(1): 5 - 8.
[Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
W. Truong, W. W. Hancock, J. C. Plester, S. Merani, D. C. Rayner, G. Thangavelu, K. M. Murphy, C. C. Anderson, and A. M. J. Shapiro
BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice
J. Leukoc. Biol., July 1, 2009; 86(1): 41 - 51.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
X. Liu, M. Alexiou, N. Martin-Orozco, Y. Chung, R. I. Nurieva, L. Ma, Q. Tian, G. Kollias, S. Lu, D. Graf, et al.
Cutting Edge: A Critical Role of B and T Lymphocyte Attenuator in Peripheral T Cell Tolerance Induction
J. Immunol., April 15, 2009; 182(8): 4516 - 4520.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. C. Vendel, J. Calemine-Fenaux, A. Izrael-Tomasevic, V. Chauhan, D. Arnott, and D. L. Eaton
B and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK
J. Immunol., February 1, 2009; 182(3): 1509 - 1517.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. W. Steinberg, O. Turovskaya, R. B. Shaikh, G. Kim, D. F. McCole, K. Pfeffer, K. M. Murphy, C. F. Ware, and M. Kronenberg
A crucial role for HVEM and BTLA in preventing intestinal inflammation
J. Exp. Med., June 9, 2008; 205(6): 1463 - 1476.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. A. Nelson, M. D. Fremont, J. R. Sedy, P. S. Norris, C. F. Ware, K. M. Murphy, and D. H. Fremont
Structural Determinants of Herpesvirus Entry Mediator Recognition by Murine B and T Lymphocyte Attenuator
J. Immunol., January 15, 2008; 180(2): 940 - 947.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. De Trez, K. Schneider, K. Potter, N. Droin, J. Fulton, P. S. Norris, S.-w. Ha, Y.-X. Fu, T. Murphy, K. M. Murphy, et al.
The Inhibitory HVEM-BTLA Pathway Counter Regulates Lymphotoxin Receptor Signaling to Achieve Homeostasis of Dendritic Cells
J. Immunol., January 1, 2008; 180(1): 238 - 248.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Lepenies, K. Pfeffer, M. A. Hurchla, T. L. Murphy, K. M. Murphy, J. Oetzel, B. Fleischer, and T. Jacobs
Ligation of B and T Lymphocyte Attenuator Prevents the Genesis of Experimental Cerebral Malaria
J. Immunol., September 15, 2007; 179(6): 4093 - 4100.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. Hurchla, J. R. Sedy, and K. M. Murphy
Unexpected Role of B and T Lymphocyte Attenuator in Sustaining Cell Survival during Chronic Allostimulation
J. Immunol., May 15, 2007; 178(10): 6073 - 6082.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Xu, A. S. Flies, D. B. Flies, G. Zhu, S. Anand, S. J. Flies, H. Xu, R. A. Anders, W. W. Hancock, L. Chen, et al.
Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease
Blood, May 1, 2007; 109(9): 4097 - 4104.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K. C. Beier, T. Kallinich, and E. Hamelmann
Master switches of T-cell activation and differentiation
Eur. Respir. J., April 1, 2007; 29(4): 804 - 812.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Chemnitz, A. R. Lanfranco, I. Braunstein, and J. L. Riley
B and T Lymphocyte Attenuator-Mediated Signal Transduction Provides a Potent Inhibitory Signal to Primary Human CD4 T Cells That Can Be Initiated by Multiple Phosphotyrosine Motifs.
J. Immunol., June 1, 2006; 176(11): 6603 - 6614.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Deppong, T. I. Juehne, M. Hurchla, L. D. Friend, D. D. Shah, C. M. Rose, T. L. Bricker, L. P. Shornick, E. C. Crouch, T. L. Murphy, et al.
Cutting Edge: B and T Lymphocyte Attenuator and Programmed Death Receptor-1 Inhibitory Receptors Are Required for Termination of Acute Allergic Airway Inflammation
J. Immunol., April 1, 2006; 176(7): 3909 - 3913.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. M. Compaan, L. C. Gonzalez, I. Tom, K. M. Loyet, D. Eaton, and S. G. Hymowitz
Attenuating Lymphocyte Activity: THE CRYSTAL STRUCTURE OF THE BTLA-HVEM COMPLEX
J. Biol. Chem., November 25, 2005; 280(47): 39553 - 39561.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Krieg, P. Han, R. Stone, O. D. Goularte, and J. Kaye
Functional Analysis of B and T Lymphocyte Attenuator Engagement on CD4+ and CD8+ T Cells
J. Immunol., November 15, 2005; 175(10): 6420 - 6427.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Tao, L. Wang, R. Han, T. Wang, Q. Ye, T. Honjo, T. L. Murphy, K. M. Murphy, and W. W. Hancock
Differential Effects of B and T Lymphocyte Attenuator and Programmed Death-1 on Acceptance of Partially versus Fully MHC-Mismatched Cardiac Allografts
J. Immunol., November 1, 2005; 175(9): 5774 - 5782.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. H. Watts and J. L. Gommerman
The LIGHT and DARC sides of herpesvirus entry mediator
PNAS, September 20, 2005; 102(38): 13365 - 13366.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. C. Cheung, I. R. Humphreys, K. G. Potter, P. S. Norris, H. M. Shumway, B. R. Tran, G. Patterson, R. Jean-Jacques, M. Yoon, P. G. Spear, et al.
From The Cover: Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway
PNAS, September 13, 2005; 102(37): 13218 - 13223.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.